Daniel Coley has recently joined the Cofounders Capital family as an associate. With 3.5 years of experience at BrightEdge, the impact investment arm of the American Cancer Society, Daniel brings valuable expertise in investing in and supporting companies focused on cancer treatments, diagnostics, and technology. Prior to his tenure at BrightEdge, Daniel served as an investment banking analyst at SunTrust Robinson Humphrey (now Truist Securities), specializing in mergers and acquisitions.
This marks Daniel’s second time working with CFC, as he previously interned with the firm in the summer of 2017. He is a graduate of Babson College, where he earned a B.S. in business administration with a particular emphasis on finance and IT management. During his time at Babson, Daniel actively participated in the varsity rugby team.